Standard or custom package
excellent quality and reliable supplier
*The following content is generated by AI and is for reference only.
Overview
Eribulin Intermediate C is a critical chiral building block for the semi-synthetic production of eribulin mesylate, a microtubule dynamics inhibitor. Synthesized via stereoselective aldol condensation, this intermediate ensures high optical purity essential for pharmaceutical efficacy.
Application
- Pharmaceutical Manufacturing: Key precursor in large-scale synthesis of eribulin for metastatic breast cancer treatment.
- API Development: Used in process chemistry to optimize yield and reduce impurities during drug substance formation.
- R&D Projects: Employed in medicinal chemistry studies exploring novel tubulin-binding analogs.
Precautions
Requires storage under inert atmosphere at controlled temperatures to prevent degradation. Strict adherence to GMP guidelines is mandatory during handling due to potential cytotoxicity risks associated with tubulin inhibitors.